Bottom line
How much do FHLC and RYHIX overlap?
80% of their top holdings overlap by weight. 23 securities appear in both funds' top 25, making up 70.4% of FHLC's assets and 34.7% of RYHIX's. They are largely the same portfolio — owning both adds little diversification.
FHLC holds far more positions (337 vs 135), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings FHLC and RYHIX have in common
| Holding | % of FHLC | % of RYHIX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 13.35% | 3.63% | 3.63% |
| Johnson & Johnson | 8.93% | 2.88% | 2.88% |
| AbbVie Inc | 6.42% | 2.52% | 2.52% |
| UnitedHealth Group Inc | 5.44% | 2.22% | 2.22% |
| Merck & Co Inc | 4.66% | 2.04% | 2.04% |
| Thermo Fisher Scientific Inc | 3.09% | 1.61% | 1.61% |
| Amgen Inc | 3.00% | 1.56% | 1.56% |
| Abbott Laboratories | 2.66% | 1.42% | 1.42% |
| Gilead Sciences Inc | 2.34% | 1.39% | 1.39% |
| Pfizer Inc | 2.06% | 1.25% | 1.25% |
| Bristol-Myers Squibb Co | 1.93% | 1.22% | 1.22% |
| CVS Health Corp | 1.92% | 1.31% | 1.31% |
| Intuitive Surgical Inc | 1.82% | 1.31% | 1.31% |
| Danaher Corp | 1.80% | 1.30% | 1.30% |
| Vertex Pharmaceuticals Inc | 1.76% | 1.34% | 1.34% |
| Stryker Corp | 1.62% | 1.21% | 1.21% |
| McKesson Corp | 1.52% | 1.05% | 1.05% |
| Elevance Health Inc | 1.19% | 1.02% | 1.02% |
| Regeneron Pharmaceuticals Inc | 1.15% | 0.90% | 0.90% |
| Cigna Group/The | 1.06% | 0.94% | 0.94% |
| Boston Scientific Corp | 1.00% | 0.86% | 0.86% |
| HCA Healthcare Inc | 0.91% | 0.87% | 0.87% |
| Cardinal Health Inc | 0.78% | 0.86% | 0.78% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FHLC
- Medtronic PLC — 1.59%
- Cencora Inc — 0.83%
Only in RYHIX
- Edwards Lifesciences Corp — 0.84%
- Novo Nordisk A/s — 0.83%
Asset mix
| Asset type | FHLC | RYHIX |
|---|---|---|
| Stocks | 99.7% | 83.2% |
| Repurchase agreements | — | 0.9% |
| Cash & short-term funds | 0.2% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FHLC | RYHIX |
|---|---|---|
| US | 96.5% | 73.0% |
| IE | 2.2% | 3.3% |
| CH | 0.1% | 2.3% |
| GB | 0.5% | 1.8% |
| DK | — | 1.4% |
| NL | 0.1% | 0.7% |
| IL | — | 0.6% |
| DE | — | 0.6% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FHLC and RYHIX overlap?
What stocks do FHLC and RYHIX have in common?
Should I own both FHLC and RYHIX?
Which holds more stocks, FHLC or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.